Global Mycotoxin Testing Market Size, Trend & Opportunity Analysis Report, by Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Other Technologies), Pathogen Type (Aflatoxins, Ochratoxin A, Patulin, Fusarium Toxins, Other Mycotoxins), and Forecast, 2025-2035

Market Definition and Introduction

The Global Mycotoxin Testing Market was valued at USD 3.46 billion in 2024 and is anticipated to reach USD 6.50 billion by 2035, expanding at a CAGR of 5.9% during the forecast period 2025-2035. As food safety continues to emerge as a non-negotiable priority across global supply chains, the growing need for mycotoxin testing solutions that are highly accurate, fast, and reliable has increased. Mycotoxins are substances produced by fungi that occur in cereals, grains, fruits, nuts, and animal feed, thereby posing severe threats to human health and livestock productivity. Hence, their detection and monitoring have emerged as key concerns for compliance with the increasingly stringent regulatory norms set by global authorities such as EFSA, USDA, and FAO.

With a steady growth in global food trade, there is an equally heightened need for harmonised testing methods, as shipments contaminated with aflatoxins or ochratoxins risk export revenue and tarnish brand names. This increased demand has also been accelerated by the growing consumer awareness of foodborne hazards. Hence, testing laboratories and technology vendors have constantly reinvented their solutions, adding multi-analyte detection capabilities, digital traceability tools, and advanced analytical platforms.

On the supply side, technology providers are therefore recalibrating their offerings to meet the high throughput needs of food processors and feed manufacturers. By harmonising rapid screening tests with confirmatory platforms such as LC-MS/MS, these solutions redefine the accuracy and scalability of testing systems. This transition reflects compliance demands but also a larger paradigm shift wherein food safety becomes a key determinant of business continuity, brand equity, and consumer trust in an interconnected global food system.

Recent Developments in the Industry

1. In March 2024, Agilent Technologies initiated sales of a next-generation LC-MS/MS platform designed for the screening of mycotoxins in cereals and feed on high throughput, presenting thereby enhanced sensitivity to allow food processors to comply, at reduced per-sample testing costs.

1. In September 2024, SGS SA joined hands with regional laboratories in the Asia-Pacific region to furnish accredited mycotoxin testing services for rice and corn. This partnership aims to enhance capacity, bring about turnaround time improvement, and maximise safety credentials for global food exports.

1. In January 2025, the European Food Safety Agency revised the tolerable limits on Fusarium toxins in processed grains, therefore, demanding enhanced analytical capabilities from exporters. This, in turn, is compelling laboratories to recalibrate their testing infrastructure to stay compliant and competitive.

1. In November 2023, Eurofins Scientific expanded its food testing facility in Brazil, adding new immunoassay-based technologies for the rapid detection of aflatoxins in maize. This expansion further cements Eurofins' presence in Latin America, a major grain exporter to the EU.

1. In April 2024, Neogen Corporation brought forth handheld immunoassay kits for farmers and feed millers to allow on-site detection of ochratoxin A. This product is made to empower frontline stakeholders so they can preemptively mitigate risk before grains enter processing chains.

1. In June 2025, R-Biopharm AG launched a multiplex ELISA kit with the ability to detect five mycotoxins simultaneously. With a substantial reduction in analysis time, the kit will now allow laboratories to provide cost-effective, high-throughput services for a variety of agricultural products.

Market Dynamics

Stringent regulatory frameworks help in speeding up global adoption of advanced mycotoxin testing technologies.

With governments worldwide enforcing harsher and harsher safety thresholds for mycotoxins in food and feed, the push has been for laboratories and processors to sink large investments into newer platforms like LC-MS/MS for high precision. The combination of customer demands and regulatory compliance has now made mycotoxin testing a business-critical activity for both exporters and local suppliers, with regulatory frameworks serving as a huge propeller of market growth.

Feedstock contamination concerns drive higher demand for animal feed safety assurance.

Poor livestock productivity due to mycotoxin contamination in feeds translates into economic losses across the meat and dairy industry. With enhanced demand for protein all over the globe, production yields need to be protected by toxin-free feed. In response, manufacturers are ramping up their routine testing of Fusarium toxins and aflatoxins, investing in strong and cost-effective analytical solutions to uphold supply continuity and livestock health.

Cost pressures and technological complexity remain restraints to widespread adoption.

The high capital costs in equipping and running, employing skilled personnel, and maintaining its upkeep limit the uptake of modern methods like LC-MS/MS with unmatched accuracy among smaller processors. Immunoassay kits are much less expensive but may not work for multi-toxin detection. The financial and technical barrier limits entry into emerging economies, creating gaps in compliance that global regulators are trying to close.

Emerging opportunities lie in portable and rapid-testing innovations.

The point-of-care diagnostic trend is giving rise to portable devices capable of analysing on-site. Immunoassay-based assays and biosensor technologies that reduce dependency on central laboratories are embraced by farmers, grain collectors, and processors. These rapid solutions thereby promise a revolutionary change in mycotoxin detection, allowing for early intervention and reducing operational costs, thus providing pivotal opportunities for industry innovators.

Mycotoxin testing integrates with blockchain for digital traceability, enhancing transparency and trust in food safety

Industry practitioners now increasingly pair mycotoxin testing results with blockchain and digital traceability platforms to provide assurance for transparency along the food chain. The integration solidifies trust among consumers, regulators, and multinational purchasers while minimising trainers' disputes in cross-border trade. This unfolding trend depicts the unslowing digitisation pace that has entered the food safety sector, with mycotoxin testing at the frontline of the defence to public health and reinforcing the trustworthiness of international trade.

Attractive Opportunities in the Market

1. Portable Testing Kits Expansion - On-site immunoassay kits empower producers to detect toxins before supply chain entry.
2. High-Throughput LC-MS/MS Growth - Large-scale laboratories adopt advanced systems to manage multi-toxin analysis efficiently.
3. Regulatory Compliance Strengthening - Stricter thresholds across the EU, US, and Asia drive innovation in analytical platforms.
4. Digital Traceability Integration - Coupling blockchain with toxin testing enhances transparency across food supply networks.
5. Emerging Market Penetration - Latin America and Africa represent untapped opportunities for rapid testing providers.
6. Multiplex Assay Development - Simultaneous detection technologies reduce costs and accelerate laboratory testing workflows.
7. Animal Feed Assurance Demand - Rising livestock industry requires consistent monitoring of Fusarium and aflatoxin levels.
8. Collaborative R&D Platforms - Joint projects between tech firms and regulators drive innovation in safety standards.
9. Sustainable Processing Alignment - Testing solutions align with sustainable agriculture by reducing food waste and recalls.
10. Point-of-Care Diagnostics Rise - Affordable field-based devices transform accessibility for smallholder farmers and traders.

Report Segmentation

By Technology: HPLC-based, LC-MS/MS-based, Immunoassay-based, Other Technologies

By Pathogen Type: Aflatoxins, Ochratoxin A, Patulin, Fusarium Toxins, Other Mycotoxins

By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)

Key Market Players: SGS SA, Eurofins Scientific, Bureau Veritas, Intertek Group plc, Neogen Corporation, R-Biopharm AG, Romer Labs, ALS Limited, Agilent Technologies, and Bio-Rad Laboratories, Inc.

Report Aspects

Base Year: 2024

Historic Years: 2022, 2023, 2024

Forecast Period: 2024-2035

Report Pages: 295

Dominating Segments

LC-MS/MS-based testing, considered the most sensitive and compliant with existing regulations, is given preference over any other method available for mycotoxin testing across the world.

Among existing technologies, LC-MS/MS systems have remained the gold standard for mycotoxin detection, enabling high resolution, multi-analyte quantification with the precision level accepted by international regulators. Laboratories around the world use this platform to simultaneously detect aflatoxins, ochratoxin A, patulin, and Fusarium toxins in food varieties with complex matrices. Though expensive and operationally very complex, LC-MS/MS remains vital, since no other technology can meet such stringent EU and US regulatory thresholds. Over the forecast period, advances in automated sample preparation for improved throughput will further strengthen the dominance of this segment to help processors in avoiding costly recalls and trade disruptions.

The Aflatoxin segment leads in the pathogen type category, reflecting more than ever-increasing risks in grains and nuts in global trade.

Food aflatoxins, which are among the most hazardous toxins in the world, are produced by Aspergillus spp. They have well-established associations with human liver cancer and some chronic effects. They are particularly infective in maize, peanuts, and tree nuts, which dominate the international commercial flows. FAO and USDA regulators set strict limits to aflatoxin content in food products, forcing exporters to adopt very strict routine testing measures that are exacting. The segment in worldwide trade continues to dominate with increasing volumes mostly between Latin America, Africa, and Europe, where non-compliance could mean rejection of consignments and a huge loss of

revenue. Demand for aflatoxin tests will soar in the coming days as climate change increases the prevalence of fungi.

Immunoassay-based testing is emerging rapidly to meet the needs for economical, on-site, and large-scale screening.

While not as accurate as LC-MS/MS, the advantages of immunoassay kits-simplicity, rapidity, and portability-have gained them strong market acceptance. Food processors, smallholder farmers, and feed producers use these tests for first screening to raise a flag on possible contamination before sending the samples for confirmatory analysis. With the advent of multiplex ELISA platforms allowing simultaneous detection of multiple toxins on a low-cost basis, this would further accelerate the segment's growth. With the food systems across the globe demanding scalable, decentralised testing solutions, immunoassay-based methods are increasingly emerging as a complementary yet integral tool, together with advanced laboratory systems.

The Fusarium toxins segment is witnessing a robust growth as live animals and feeds are subject to the utmost scrutiny.

Fusarium toxins like deoxynivalenol (DON) and fumonisins pose a huge threat to animal health by reducing productivity and increasing veterinary costs; protein production demand is, therefore, pushing feed manufacturers on an alarming side to really test for less contamination. Thus, regulatory agencies in Europe and North America implement stringent limits on Fusarium toxin content and compel feed producers to use rapid screening and confirmatory technologies. Growing awareness of cross-contamination risk and climate-verged fungal growth enhances momentum for this category, marking it as one of the fastest-growing categories for pathogenic types.

Key Takeaways

1. LC-MS/MS Dominance - Advanced detection technologies remain the gold standard for multi-toxin quantification under global regulations.
2. Aflatoxin Priority - Stringent limits on maize, nuts, and cereals maintain aflatoxins as the most frequently tested toxin.
3. Affordable Immunoassays - Rapid screening kits expand access to smaller producers and decentralised food systems worldwide.
4. Fusarium Toxin Growth - Expanding livestock sector boosts demand for rigorous feed testing protocols across major regions.
5. Regulatory Pressure - Tighter EFSA and USDA standards drive adoption of more sensitive and scalable testing technologies.
6. Digital Integration - Blockchain-enabled traceability strengthens trust and market access for exporters in food supply chains.
7. Field Testing Expansion - Point-of-care solutions enable frontline testing and empower smallholder farmers to reduce risks.
8. Emerging Market Penetration - Latin America and Africa represent growth frontiers for cost-effective rapid testing systems.
9. R&D Collaborations - Partnerships between regulators and laboratories accelerate innovation in multi-toxin detection kits.
10. Food Safety Branding - Companies leveraging advanced testing gain a competitive advantage by reinforcing trust and compliance.

Regional Insights

North America leads mycotoxin testing with strict regulations, advanced labs, and precision food safety standards

North America asserts leadership internationally with sophisticated regulatory enforcement and heavy investment in test infrastructures.

Mycotoxin testing in the United States and Canada is further supported by stringent standards from the FDA and USDA, and the high adoption rates of LC-MS/MS systems across laboratories reflect the high precision that the region wishes to attach to maize, dairy, and processed foods. Furthermore, increased demand for feed safety testing is amplified by the expansion of the livestock industry, in addition to investments in innovative platforms by leading players such as Neogen and Agilent Technologies. Because exports of food take a huge chunk of trade, testing protocols in North America are fast being conferred the honour of benchmarks in international markets.

Europe leads in mycotoxin compliance with harmonised testing, multi-toxin labs, and innovative detection technologies

Europe is leading on green compliance as well as on harmonised testing frameworks for mycotoxins across food and feed categories. It is a market that is heavily regulated, hence some of the strictest limits on mycotoxins globally are set by EFSA guidelines. Germany, France, and the Netherlands are places of centrality in innovation in laboratories relative to multi-toxin detection systems. Harmonisation across EU member states testifies towards the same for cereals, dairy, and processed food exports. In addition to that, high investments in research collaboration with academic institutions fuel the development of rapid and sustainable detection technologies, thus solidifying Europe's superiority in introducing innovations geared towards food safety and compliance.

Asia-Pacific leads global mycotoxin testing growth with exports, safety standards, and lab expansion

Asia-Pacific outgrew its neighbouring market and emerged as the fastest-growing region on the basis of heightened agricultural exports and

improved domestic food safety standards. China, India, and Southeast Asia are quickly ramping up mycotoxin testing with increasing global exports of grains and nuts. Domestic regulators are tightening safety thresholds and aligning them with EU and US standards, wherein reliance is placed on immunoassays and LC-MS/MS platforms to meet these standards. Growth in consumer awareness and recurrence of contamination incidents also spur the building of testing laboratories regionally. This has led to local players working with global giants like Eurofins and SGS to increase capacity and enhance technical expertise that, when combined, create what is known to be the most promising frontier for market development in Asia-Pacific.

LAMEA strengthens its presence through export-driven compliance and regional laboratory investments.

Latin America, mainly through Brazil and Argentina, acts as one of the important suppliers of grains to Europe and Asia. Thus, stringent testing protocols are required so that the grains can meet international standards for trade. The increasing incidences of aflatoxin contamination in maize and peanuts have forced exporters to forge stronger ties with global laboratories. In the Middle East and Africa, immunoassay-based rapid tests are expected to take root as governments mention food safety modernisation. Investments in laboratory infrastructure, especially in the UAE and South Africa, are a long-term commitment to the full integration of advanced testing into agricultural value chains.

Core Strategic Questions Answered in This Report

Q. What is the expected growth trajectory of the mycotoxin testing market from 2024 to 2035?

The global mycotoxin testing market is projected to grow from USD 3.46 billion in 2024 to USD 6.50 billion by 2035, registering a CAGR of 5.9%. Growth is driven by regulatory compliance, rising food safety concerns, and increasing adoption of advanced technologies.

Q. Which key factors are fuelling the growth of the mycotoxin testing market?

Several factors are propelling market expansion, including heightened global food safety regulations, rapid growth in food exports, integration of digital traceability, rising contamination risks due to climate change, and increased R&D investments in multi-toxin detection technologies.

Q. What are the primary challenges hindering the growth of the mycotoxin testing market?

Challenges include the high cost of advanced testing platforms, limited adoption in smallholder-dominated economies, technological complexity in multi-toxin detection, and uneven regulatory enforcement across developing regions.

Q. Which regions currently lead the mycotoxin testing market in terms of market share?

North America leads the market owing to strong regulatory enforcement and widespread adoption of LC-MS/MS systems. Europe follows closely, dominating in harmonised regulatory frameworks and innovation, while Asia-Pacific is the fastest-growing region.

Q. What emerging opportunities are anticipated in the mycotoxin testing market?

The market is poised for opportunities in portable testing innovations, multiplex assay developments, digital traceability integration, and expansion in emerging markets. Growing collaborations between regulators and private laboratories will further enhance detection capabilities.

Key Benefits for Stakeholders

1. The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
2. The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
3. Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
4. A detailed examination of market segmentation helps identify existing and emerging opportunities.
5. Key countries within each region are analysed based on their revenue contributions to the overall market.
6. The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
7. The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.

Chapter 1. Market Snapshot

1.1. Market Definition & Report Overview

1.2. Market Segmentation

1.3. Key Takeaways

1.3.1. Top Investment Pockets

1.3.2. Top Winning Strategies

1.3.3. Market Indicators Analysis

1.3.4. Top Impacting Factors

1.4. Industry Ecosystem Analysis

1.4.1. 360-Analysis

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint

2.2. Strategic Insights

2.3. ESG Analysis

2.4 Market Attractiveness Analysis

2.5. key Findings

Chapter 3. Research Methodology

3.1 Research Objective

3.2 Supply Side Analysis

3.2.1. Primary Research

3.2.2. Secondary Research

3.3 Demand Side Analysis

3.3.1. Primary Research

3.3.2. Secondary Research

3.4. Forecasting Models

3.4.1. Assumptions

3.4.2. Forecasts Parameters

3.5. Competitive breakdown

3.5.1. Market Positioning

3.5.2. Competitive Strength

3.6. Scope of the Study

3.6.1. Research Assumption

3.6.2. Inclusion & Exclusion

3.6.3. Limitations

Chapter 4. Industry Landscape

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Porter's 5 Forces Model

4.2.1. Bargaining Power of Buyer

4.2.2. Bargaining Power of Supplier

4.2.3. Threat of New Entrants

4.2.4. Threat of Substitutes

4.2.5. Competitive Rivalry

4.3. Value Chain Analysis

4.4. PESTEL Analysis

4.5. Pricing Analysis and Trends

4.6. Key growth factors and trends analysis

4.7. Market Share Analysis (2025)

4.8. Top Winning Strategies (2025)

4.9. Trade Data Analysis (Import Export)

4.10. Regulatory Guidelines

4.11. Historical Data Analysis

4.12. Analyst Recommendation & Conclusion

Chapter 5. Global Mycotoxin Testing Market Size & Forecasts by Technology 2024-2035

5.1. Market Overview

5.1.1. Market Size and Forecast By Technology 2024-2035

5.2. HPLC-based

5.2.1. Market definition, current market trends, growth factors, and opportunities

5.2.2. Market size analysis, by region, 2024-2035

5.2.3. Market share analysis, by country, 2024-2035

5.3. LC-MS/MS-based

5.3.1. Market definition, current market trends, growth factors, and opportunities

5.3.2. Market size analysis, by region, 2024-2035

5.3.3. Market share analysis, by country, 2024-2035

5.4. Immunoassay-based

5.4.1. Market definition, current market trends, growth factors, and opportunities

5.4.2. Market size analysis, by region, 2024-2035

5.4.3. Market share analysis, by country, 2024-2035

5.5. Other Technologies

5.5.1. Market definition, current market trends, growth factors, and opportunities

5.5.2. Market size analysis, by region, 2024-2035

5.5.3. Market share analysis, by country, 2024-2035

Chapter 6. Global Mycotoxin Testing Market Size & Forecasts by Pathogen Type 2024-2035

6.1. Market Overview

6.1.1. Market Size and Forecast By Pathogen Type 2024-2035

6.2. Aflatoxins

6.2.1. Market definition, current market trends, growth factors, and opportunities

6.2.2. Market size analysis, by region, 2024-2035

6.2.3. Market share analysis, by country, 2024-2035

6.3. Ochratoxin A

6.3.1. Market definition, current market trends, growth factors, and opportunities

6.3.2. Market size analysis, by region, 2024-2035

6.3.3. Market share analysis, by country, 2024-2035

6.4. Patulin

6.4.1. Market definition, current market trends, growth factors, and opportunities

6.4.2. Market size analysis, by region, 2024-2035

6.4.3. Market share analysis, by country, 2024-2035

6.5. Fusarium Toxins

6.5.1. Market definition, current market trends, growth factors, and opportunities

6.5.2. Market size analysis, by region, 2024-2035

6.5.3. Market share analysis, by country, 2024-2035

6.6. Other Mycotoxins

6.6.1. Market definition, current market trends, growth factors, and opportunities

6.6.2. Market size analysis, by region, 2024-2035

6.6.3. Market share analysis, by country, 2024-2035

Chapter 7. Global Mycotoxin Testing Market Size & Forecasts by Region 2024-2035

7.1. Regional Overview 2024-2035

7.2. Top Leading and Emerging Nations

7.3. North America Mycotoxin Testing Market

7.3.1. U.S. Mycotoxin Testing Market

7.3.1.1. By Technology breakdown size & forecasts, 2024-2035

7.3.1.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.3.2. Canada Mycotoxin Testing Market

7.3.2.1. By Technology breakdown size & forecasts, 2024-2035

7.3.2.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.3.3. Mexico Mycotoxin Testing Market

7.3.3.1. By Technology breakdown size & forecasts, 2024-2035

7.3.3.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.4. Europe Mycotoxin Testing Market

7.4.1. UK Mycotoxin Testing Market

7.4.1.1. By Technology breakdown size & forecasts, 2024-2035

7.4.1.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.4.2. Germany Mycotoxin Testing Market

7.4.2.1. By Technology breakdown size & forecasts, 2024-2035

7.4.2.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.4.3. France Mycotoxin Testing Market

7.4.3.1. By Technology breakdown size & forecasts, 2024-2035

7.4.3.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.4.4. Spain Mycotoxin Testing Market

7.4.4.1. By Technology breakdown size & forecasts, 2024-2035

7.4.4.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.4.5. Italy Mycotoxin Testing Market

7.4.5.1. By Technology breakdown size & forecasts, 2024-2035

7.4.5.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.4.6. Rest of Europe Mycotoxin Testing Market

7.4.6.1. By Technology breakdown size & forecasts, 2024-2035

7.4.6.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.5. Asia Pacific Mycotoxin Testing Market

7.5.1. China Mycotoxin Testing Market

7.5.1.1. By Technology breakdown size & forecasts, 2024-2035

7.5.1.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.5.2. India Mycotoxin Testing Market

7.5.2.1. By Technology breakdown size & forecasts, 2024-2035

7.5.2.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.5.3. Japan Mycotoxin Testing Market

7.5.3.1. By Technology breakdown size & forecasts, 2024-2035

7.5.3.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.5.4. Australia Mycotoxin Testing Market

7.5.4.1. By Technology breakdown size & forecasts, 2024-2035

7.5.4.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.5.5. South Korea Mycotoxin Testing Market

7.5.5.1. By Technology breakdown size & forecasts, 2024-2035

7.5.5.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.5.6. Rest of APAC Mycotoxin Testing Market

7.5.6.1. By Technology breakdown size & forecasts, 2024-2035

7.5.6.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.6. LAMEA Mycotoxin Testing Market

7.6.1. Brazil Mycotoxin Testing Market

7.6.1.1. By Technology breakdown size & forecasts, 2024-2035

7.6.1.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.6.2. Argentina Mycotoxin Testing Market

7.6.2.1. By Technology breakdown size & forecasts, 2024-2035

7.6.2.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.6.3. UAE Mycotoxin Testing Market

7.6.3.1. By Technology breakdown size & forecasts, 2024-2035

7.6.3.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.6.4. Saudi Arabia (KSA Mycotoxin Testing Market

7.6.4.1. By Technology breakdown size & forecasts, 2024-2035

7.6.4.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.6.5. Africa Mycotoxin Testing Market

7.6.5.1. By Technology breakdown size & forecasts, 2024-2035

7.6.5.2. By Pathogen Type breakdown size & forecasts, 2024-2035

7.6.6. Rest of LAMEA Mycotoxin Testing Market

7.6.6.1. By Technology breakdown size & forecasts, 2024-2035

7.6.6.2. By Pathogen Type breakdown size & forecasts, 2024-2035

Chapter 8. Company Profiles

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. SGS SA

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.2. Eurofins Scientific

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.3. Bureau Veritas

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.4. Intertek Group plc

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.5. Neogen Corporation

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.6. R-Biopharm AG

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.7. Romer Labs

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.8. ALS Limited

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.9. Agilent Technologies

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis

8.2.10. Bio-Rad Laboratories, Inc.

8.2.1.1. Company Overview

8.2.1.2. Key Executives

8.2.1.3. Company Snapshot

8.2.1.4. Financial Performance

8.2.1.5. Product/Services Port

8.2.1.6. Recent Development

8.2.1.7. Market Strategies

8.2.1.8. SWOT Analysis